MicroRNAs and lung cancer: New oncogenes and tumor suppressors, new prognostic factors and potential therapeutic targets

Current Medicinal Chemistry

Volumn 16, Issue 9, 2009, Pages 1047-1061

  Ortholan, Cécile ^a,b   Puissegur, Marie Pierre ^c,d   Ilie, Marius ^a,d,e   Barbry, Pascal ^c,d   Mari, Bernard ^c,d   Hofman, Paul ^a,d,e  

^a PASTEUR HOSPITAL   (France)

^b CENTRE ANTOINE LACASSAGNE   (France)

^c INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^d UNIVERSITÉ CÔTE D'AZUR   (France)

^e INSERM   (France)

Author keywords

Cancer; Diagnosis; Lung; MicroRNA; Prognosis; Therapeutic target

Indexed keywords

ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; BEVASIRANIB; CONNECTIVE TISSUE GROWTH FACTOR; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DNA METHYLTRANSFERASE; ERLOTINIB; GEFITINIB; HIGH MOBILITY GROUP A2 PROTEIN; K RAS PROTEIN; MESSENGER RNA; MICRORNA; MYC PROTEIN; PACLITAXEL; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN P53; RAS PROTEIN; RETROVIRUS VECTOR; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; THROMBOSPONDIN 1; TRANSCRIPTION FACTOR E2F1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

3' UNTRANSLATED REGION; ANTINEOPLASTIC ACTIVITY; ANTISENSE THERAPY; CANCER GROWTH; CHROMOSOME REARRANGEMENT; CLINICAL TRIAL; CYTOTOXICITY; DRUG RESPONSE; DRUG SENSITIVITY; EPIGENETICS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC VARIABILITY; HUMAN; LUNG CANCER; LUNG CARCINOGENESIS; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SURGERY; NONHUMAN; ONCOGENE; PREDICTION; PROGNOSIS; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RNA ANALYSIS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE; VIRAL GENE DELIVERY SYSTEM;

DRUG DELIVERY SYSTEMS; HUMANS; LUNG NEOPLASMS; MICRORNAS; PROGNOSIS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 65649152994     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986709787581833     Document Type: Review

References (176)

1. Lee, R.; Feinbaum, R.; Ambros, V. A short history of a short RNA. Cell, 2004, 116, S89-92, 1 p following S96.
2. Bartel, D. P. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell, 2004, 116, 281-97.
3. Valencia-Sanchez, M. A.; Liu, J.; Hannon, G. J.; Parker, R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev., 2006, 20, 515-24.
4. Pillai, R. S.; Bhattacharyya, S. N.; Filipowicz, W. Repression of protein synthesis by miRNAs: How many mechanisms? Trends Cell Biol., 2007, 17, 118-26.
5. Lee, Y.; Jeon, K.; Lee, J. T.; Kim, S.; Kim, V. N. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J., 2002, 21, 4663-70.
6. Gregory, R. I.; Yan, K. P.; Amuthan, G.; Chendrimada, T.; Doratotaj, B.; Cooch, N.; Shiekhattar, R. The Microprocessor complex mediates the genesis of microRNAs. Nature, 2004, 432, 235-40
7. Denli, A. M.; Tops, B. B.; Plasterk, R. H.; Ketting, R. F.; Hannon, G. J. Processing of primary microRNAs by the Microprocessor complex. Nature, 2004, 432, 231-5.
8. Peters, L.; Meister, G. Argonaute proteins: Mediators of RNA silencing. Mol. Cell, 2007, 26, 611-23.
9. Lewis, B. P.; Burge, C. B.; Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 2005, 120, 15-20.
10. Brennecke, J.; Stark, A.; Russell, R. B.; Cohen, S. M. Principles of MicroRNA-Target Recognition. PLoS Biol., 2005, 3, e85.
11. Doench, J. G.; Sharp, P. A. Specificity of microRNA target selection in translational repression. Genes Dev., 2004, 18, 504-11.
12. Filipowicz, W.; Bhattacharyya, S. N.; Sonenberg, N. Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight? Nat. Rev. Genet., 2008, 9, 102-14.
13. Xie, X.; Lu, J.; Kulbokas, E. J.; Golub, T. R.; Mootha, V.; Lindblad-Toh, K.; Lander, E. S.; Kellis, M. Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals. Nature, 2005, 434, 338-45.
14. Griffiths-Jones, S.; Grocock, R. J.; van Dongen, S.; Bateman, A.; Enright, A. J. miRBase: MicroRNA sequences, targets and gene nomenclature. Nucleic Acids Res., 2006, 34, D140-4.
15. Calin, G. A.; Dumitru, C. D.; Shimizu, M.; Bichi, R.; Zupo, S.; Noch, E.; Aldler, H.; Rattan, S.; Keating, M.; Rai, K.; Rassenti, L.; Kipps, T.; Negrini, M.; Bullrich, F.; Croce, C. M. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA, 2002, 99, 15524-9.
16. Esquela-Kerscher, A.; Slack, F. J. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer, 2006, 6, 259-69.
17. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Murray, T.; Thun, M. J. Cancer statistics, 2008. CA Cancer J. Clin., 2008, 58, 71-96.
18. D'Amico, T. A. Molecular biologic staging of lung cancer. Ann. Thorac. Surg., 2008, 85, S737-42.
19. Harpole, D. H., Jr. Prognostic modeling in early stage lung cancer: An evolving process from histopathology to genomics. Thorac. Surg. Clin., 2007, 17, 167-73, viii.
20. Lu, J.; Getz, G.; Miska, E. A.; Alvarez-Saavedra, E.; Lamb, J.; Peck, D.; Sweet-Cordero, A.; Ebert, B. L.; Mak, R. H.; Ferrando, A. A.; Downing, J. R.; Jacks, T.; Horvitz, H. R.; Golub, T. R. MicroRNA expression profiles classify human cancers. Nature, 2005, 435, 834-8.
21. Shi, R.; Chiang, V. L. Facile means for quantifying microRNA expression by real-time PCR. Biotechniques, 2005, 39, 519-25
22. Liu, C. G.; Calin, G. A.; Meloon, B.; Gamliel, N.; Sevignani, C.; Ferracin, M.; Dumitru, C. D.; Shimizu, M.; Zupo, S.; Dono, M.; Alder, H.; Bullrich, F.; Negrini, M.; Croce, C. M. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc. Natl. Acad. Sci. USA, 2004, 101, 9740-4.
23. Liu, C. G.; Calin, G. A.; Volinia, S.; Croce, C. M. MicroRNA expression profiling using microarrays. Nat. Protoc., 2008, 3, 563-78.
24. Shingara, J.; Keiger, K.; Shelton, J.; Laosinchai-Wolf, W.; Powers, P.; Conrad, R.; Brown, D.; Labourier, E. An optimized isolation and labeling platform for accurate microRNA expression profiling. RNA, 2005, 11, 1461-70.
25. Sun, Y.; Koo, S.; White, N.; Peralta, E.; Esau, C.; Dean, N. M.; Perera, R. J. Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. Nucleic Acids Res., 2004, 32, e188.
26. Wang, H.; Ach, R. A.; Curry, B. Direct and sensitive miRNA profiling from low-input total RNA. RNA, 2007, 13, 151-9
27. Triboulet, R.; Mari, B.; Lin, Y. L.; Chable-Bessia, C.; Bennasser, Y.; Lebrigand, K.; Cardinaud, B.; Maurin, T.; Barbry, P.; Baillat, V.; Reynes, J.; Corbeau, P.; Jeang, K. T.; Benkirane, M. Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science, 2007, 315, 1579-82.
28. Castoldi, M.; Schmidt, S.; Benes, V.; Noerholm, M.; Kulozik, A. E.; Hentze, M. W.; Muckenthaler, M. U. A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA). RNA, 2006, 12, 913-20.
29. Nelson, P. T.; Baldwin, D. A.; Scearce, L. M.; Oberholtzer, J. C.; Tobias, J. W.; Mourelatos, Z. Microarray-based, high-throughput gene expression profiling of microRNAs. Nat. Methods, 2004, 1, 155-61.
30. Jonstrup, S. P.; Koch, J.; Kjems, J. A microRNA detection system based on padlock probes and rolling circle amplification. RNA, 2006, 12, 1747-52.
31. Friedlander, M. R.; Chen, W.; Adamidi, C.; Maaskola, J.; Einspanier, R.; Knespel, S.; Rajewsky, N. Discovering microRNAs from deep sequencing data using miRDeep. Nat. Biotechnol., 2008, 26, 407-15.
32. Thompson, R. C.; Deo, M.; Turner, D. L. Analysis of microRNA expression by in situ hybridization with RNA oligonucleotide probes. Methods, 2007, 43, 153-61.
33. Wienholds, E.; Kloosterman, W. P.; Miska, E.; Alvarez-Saavedra, E.; Berezikov, E.; de Bruijn, E.; Horvitz, H. R.; Kauppinen, S.; Plasterk, R. H. MicroRNA expression in zebrafish embryonic development. Science, 2005, 309, 310-1.
34. Kloosterman, W. P.; Wienholds, E.; de Bruijn, E.; Kauppinen, S.; Plasterk, R. H. In situ detection of miRNAs in animal embryos using LNA-modified oligonucleotide probes. Nat. Methods, 2006, 3, 27-9.
35. Darnell, D. K.; Kaur, S.; Stanislaw, S.; Konieczka, J. H.; Yatskievych, T. A.; Antin, P. B. MicroRNA expression during chick embryo development. Dev. Dyn., 2006, 235, 3156-65.
36. Nelson, P. T.; Baldwin, D. A.; Kloosterman, W. P.; Kauppinen, S.; Plasterk, R. H.; Mourelatos, Z. RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain. RNA, 2006, 12, 187-91.
37. Wulczyn, F. G.; Smirnova, L.; Rybak, A.; Brandt, C.; Kwidzinski, E.; Ninnemann, O.; Strehle, M.; Seiler, A.; Schumacher, S.; Nitsch, R. Post-transcriptional regulation of the let-7 microRNA during neural cell specification. FASEB J., 2007, 21, 415-26.
38. Deo, M.; Yu, J. Y.; Chung, K. H.; Tippens, M.; Turner, D. L. Detection of mammalian microRNA expression by in situ hybridization with RNA oligonucleotides. Dev. Dyn., 2006, 235, 2538-48
39. Obernosterer, G.; Leuschner, P. J.; Alenius, M.; Martinez, J. Post-transcriptional regulation of microRNA expression. RNA, 2006, 12, 1161-7.
40. Kiriakidou, M.; Nelson, P. T.; Kouranov, A.; Fitziev, P.; Bouyioukos, C.; Mourelatos, Z.; Hatzigeorgiou, A. A combined computational-experimental approach predicts human microRNA targets. Genes Dev., 2004, 18, 1165-78.
41. Krek, A.; Grun, D.; Poy, M. N.; Wolf, R.; Rosenberg, L.; Epstein, E. J.; MacMenamin, P.; da Piedade, I.; Gunsalus, K. C.; Stoffel, M.; Rajewsky, N. Combinatorial microRNA target predictions. Nat. Genet., 2005, 37, 495-500.
42. Lewis, B. P.; Shih, I. H.; Jones-Rhoades, M. W.; Bartel, D. P.; Burge, C. B. Prediction of mammalian microRNA targets. Cell, 2003, 115, 787-98.
43. Miranda, K. C.; Huynh, T.; Tay, Y.; Ang, Y. S.; Tam, W. L.; Thomson, A. M.; Lim, B.; Rigoutsos, I. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell, 2006, 126, 1203-17.
44. Rajewsky, N.; Socci, N. D. Computational identification of microRNA targets. Dev. Biol., 2004, 267, 529-35.
45. Rajewsky, N. microRNA target predictions in animals. Nat. Genet., 2006, 38 Suppl, S8-13.
46. Lim, L. P.; Lau, N. C.; Garrett-Engele, P.; Grimson, A.; Schelter, J. M.; Castle, J.; Bartel, D. P.; Linsley, P. S.; Johnson, J. M. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature, 2005, 433, 769-73.
47. Rodriguez, A.; Vigorito, E.; Clare, S.; Warren, M. V.; Couttet, P.; Soond, D. R.; van Dongen, S.; Grocock, R. J.; Das, P. P.; Miska, E. A.; Vetrie, D.; Okkenhaug, K.; Enright, A. J.; Dougan, G.; Turner, M.; Bradley, A. Requirement of bic/microRNA-155 for normal immune function. Science, 2007, 316, 608-11.
48. Vigorito, E.; Perks, K. L.; Abreu-Goodger, C.; Bunting, S.; Xiang, Z.; Kohlhaas, S.; Das, P. P.; Miska, E. A.; Rodriguez, A.; Bradley, A.; Smith, K. G.; Rada, C.; Enright, A. J.; Toellner, K. M.; Maclennan, I. C.; Turner, M. microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity, 2007, 27, 847-59.
49. Huang, J.; Liang, Z.; Yang, B.; Tian, H.; Ma, J.; Zhang, H. Derepression of microRNA-mediated protein translation inhibition by apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G) and its family members. J. Biol. Chem., 2007, 282, 33632-40.
50. Karginov, F. V.; Conaco, C.; Xuan, Z.; Schmidt, B. H.; Parker, J. S.; Mandel, G.; Hannon, G. J. A biochemical approach to identifying microRNA targets. Proc. Natl. Acad. Sci. USA, 2007, 104, 19291-6.
51. Keene, J. D.; Komisarow, J. M.; Friedersdorf, M. B. RIP-Chip: The isolation and identification of mRNAs, microRNAs and protein components of ribonucleoprotein complexes from cell extracts. Nat. Protoc., 2006, 1, 302-7.
52. Hendrickson, D. G.; Hogan, D. J.; Herschlag, D.; Ferrell, J. E.; Brown, P. O. Systematic identification of mRNAs recruited to argonaute 2 by specific microRNAs and corresponding changes in transcript abundance. PLoS ONE, 2008, 3, e2126.
53. Selbach, M.; Schwanhausser, B.; Thierfelder, N.; Fang, Z.; Khanin, R.; Rajewsky, N. Widespread changes in protein synthesis induced by microRNAs. Nature, 2008, 455, 58-63.
54. Baek, D.; Villen, J.; Shin, C.; Camargo, F. D.; Gygi, S. P.; Bartel, D. P. The impact of microRNAs on protein output. Nature, 2008, 455, 64-71.
55. Cimmino, A.; Calin, G. A.; Fabbri, M.; Iorio, M. V.; Ferracin, M.; Shimizu, M.; Wojcik, S. E.; Aqeilan, R. I.; Zupo, S.; Dono, M.; Rassenti, L.; Alder, H.; Volinia, S.; Liu, C. G.; Kipps, T. J.; Negrini, M.; Croce, C. M. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. USA, 2005, 102, 13944-9
56. Volinia, S.; Calin, G. A.; Liu, C. G.; Ambs, S.; Cimmino, A.; Petrocca, F.; Visone, R.; Iorio, M.; Roldo, C.; Ferracin, M.; Prueitt, R. L.; Yanaihara, N.; Lanza, G.; Scarpa, A.; Vecchione, A.; Negrini, M.; Harris, C. C.; Croce, C. M. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA, 2006, 103, 2257-61.
57. Yanaihara, N.; Caplen, N.; Bowman, E.; Seike, M.; Kumamoto, K.; Yi, M.; Stephens, R. M.; Okamoto, A.; Yokota, J.; Tanaka, T.; Calin, G. A.; Liu, C. G.; Croce, C. M.; Harris, C. C. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell, 2006, 9, 189-98.
58. Reinhart, B. J.; Slack, F. J.; Basson, M.; Pasquinelli, A. E.; Bettinger, J. C.; Rougvie, A. E.; Horvitz, H. R.; Ruvkun, G. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature, 2000, 403, 901-6.
59. Pasquinelli, A. E.; Reinhart, B. J.; Slack, F.; Martindale, M. Q.; Kuroda, M. I.; Maller, B.; Hayward, D. C.; Ball, E. E.; Degnan, B.; Muller, P.; Spring, J.; Srinivasan, A.; Fishman, M.; Finnerty, J.; Corbo, J.; Levine, M.; Leahy, P.; Davidson, E.; Ruvkun, G. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature, 2000, 408, 86-9.
60. Takamizawa, J.; Konishi, H.; Yanagisawa, K.; Tomida, S.; Osada, H.; Endoh, H.; Harano, T.; Yatabe, Y.; Nagino, M.; Nimura, Y.; Mitsudomi, T.; Takahashi, T. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res., 2004, 64, 3753-6.
61. Shell, S.; Park, S. M.; Radjabi, A. R.; Schickel, R.; Kistner, E. O.; Jewell, D. A.; Feig, C.; Lengyel, E.; Peter, M. E. Let-7 expression defines two differentiation stages of cancer. Proc. Natl. Acad. Sci. USA, 2007, 104, 11400-5.
62. Johnson, S. M.; Grosshans, H.; Shingara, J.; Byrom, M.; Jarvis, R.; Cheng, A.; Labourier, E.; Reinert, K. L.; Brown, D.; Slack, F. J. RAS is regulated by the let-7 microRNA family. Cell, 2005, 120, 635-47.
63. Inamura, K.; Togashi, Y.; Nomura, K.; Ninomiya, H.; Hiramatsu, M.; Satoh, Y.; Okumura, S.; Nakagawa, K.; Ishikawa, Y. let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis. Lung Cancer, 2007, 58, 392-6.
64. Sampson, V. B.; Rong, N. H.; Han, J.; Yang, Q.; Aris, V.; Soteropoulos, P.; Petrelli, N. J.; Dunn, S. P.; Krueger, L. J. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res., 2007, 67, 9762-70.
65. Johnson, C. D.; Esquela-Kerscher, A.; Stefani, G.; Byrom, M.; Kelnar, K.; Ovcharenko, D.; Wilson, M.; Wang, X.; Shelton, J.; Shingara, J.; Chin, L.; Brown, D.; Slack, F. J. The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res., 2007, 67, 7713-22.
66. Lee, E. J.; Gusev, Y.; Jiang, J.; Nuovo, G. J.; Lerner, M. R.; Frankel, W. L.; Morgan, D. L.; Postier, R. G.; Brackett, D. J.; Schmittgen, T. D. Expression profiling identifies microRNA signature in pancreatic cancer. Int. J. Cancer, 2007, 120, 1046-54.
67. Mayr, C.; Hemann, M. T.; Bartel, D. P. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science, 2007, 315, 1576-9.
68. Park, S. M.; Shell, S.; Radjabi, A. R.; Schickel, R.; Feig, C.; Boyerinas, B.; Dinulescu, D. M.; Lengyel, E.; Peter, M. E. Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2. Cell Cycle, 2007, 6, 2585-90.
69. Kumar, M. S.; Erkeland, S. J.; Pester, R. E.; Chen, C. Y.; Ebert, M. S.; Sharp, P. A.; Jacks, T. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc. Natl. Acad. Sci. USA, 2008, 105, 3903-8.
70. He, L.; Thomson, J. M.; Hemann, M. T.; Hernando-Monge, E.; Mu, D.; Goodson, S.; Powers, S.; Cordon-Cardo, C.; Lowe, S. W.; Hannon, G. J.; Hammond, S. M. A microRNA polycistron as a potential human oncogene. Nature, 2005, 435, 828-33.
71. Hayashita, Y.; Osada, H.; Tatematsu, Y.; Yamada, H.; Yanagisawa, K.; Tomida, S.; Yatabe, Y.; Kawahara, K.; Sekido, Y.; Takahashi, T. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res., 2005, 65, 9628-32.
72. Cully, M.; You, H.; Levine, A. J.; Mak, T. W. Beyond PTEN mutations: The PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat. Rev. Cancer, 2006, 6, 184-92.
73. Salmena, L.; Carracedo, A.; Pandolfi, P. P. Tenets of PTEN tumor suppression. Cell, 2008, 133, 403-14.
74. Ventura, A.; Young, A. G.; Winslow, M. M.; Lintault, L.; Meissner, A.; Erkeland, S. J.; Newman, J.; Bronson, R. T.; Crowley, D.; Stone, J. R.; Jaenisch, R.; Sharp, P. A.; Jacks, T. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell, 2008, 132, 875-86.
75. Wikenheiser-Brokamp, K. A. Rb family proteins differentially regulate distinct cell lineages during epithelial development. Development, 2004, 131, 4299-310.
76. Xue Jun, H.; Gemma, A.; Hosoya, Y.; Matsuda, K.; Nara, M.; Hosomi, Y.; Okano, T.; Kurimoto, F.; Seike, M.; Takenaka, K.; Yoshimura, A.; Toyota, M.; Kudoh, S. Reduced transcription of the RB2/p130 gene in human lung cancer. Mol. Carcinog., 2003, 38, 124-9.
77. O'Donnell, K. A.; Wentzel, E. A.; Zeller, K. I.; Dang, C. V.; Mendell, J. T. c-Myc-regulated microRNAs modulate E2F1 expression. Nature, 2005, 435, 839-43.
78. Matsumura, I.; Tanaka, H.; Kanakura, Y. E2F1 and c-Myc in cell growth and death. Cell Cycle, 2003, 2, 333-8.
79. Sylvestre, Y.; De Guire, V.; Querido, E.; Mukhopadhyay, U. K.; Bourdeau, V.; Major, F.; Ferbeyre, G.; Chartrand, P. An E2F/miR-20a autoregulatory feedback loop. J. Biol. Chem., 2007, 282, 2135-43
80. Woods, K.; Thomson, J. M.; Hammond, S. M. Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J. Biol. Chem., 2007, 282, 2130-4.
81. Matsubara, H.; Takeuchi, T.; Nishikawa, E.; Yanagisawa, K.; Hayashita, Y.; Ebi, H.; Yamada, H.; Suzuki, M.; Nagino, M.; Nimura, Y.; Osada, H.; Takahashi, T. Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Oncogene, 2007, 26, 6099-105.
82. Dews, M.; Homayouni, A.; Yu, D.; Murphy, D.; Sevignani, C.; Wentzel, E.; Furth, E. E.; Lee, W. M.; Enders, G. H.; Mendell, J. T.; Thomas-Tikhonenko, A. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat. Genet., 2006, 38, 1060-5.
83. Kluiver, J.; Poppema, S.; de Jong, D.; Blokzijl, T.; Harms, G.; Jacobs, S.; Kroesen, B. J.; van den Berg, A. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J. Pathol., 2005, 207, 243-9.
84. Eis, P. S.; Tam, W.; Sun, L.; Chadburn, A.; Li, Z.; Gomez, M. F.; Lund, E.; Dahlberg, J. E. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. USA, 2005, 102, 3627-32.
85. Kluiver, J.; Haralambieva, E.; de Jong, D.; Blokzijl, T.; Jacobs, S.; Kroesen, B. J.; Poppema, S.; van den Berg, A. Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. Genes Chromosomes Cancer, 2006, 45, 147-53.
86. Metzler, M.; Wilda, M.; Busch, K.; Viehmann, S.; Borkhardt, A. High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer, 2004, 39, 167-9.
87. Rai, D.; Karanti, S.; Jung, I.; Dahia, P. L.; Aguiar, R. C. Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma. Cancer Genet. Cytogenet., 2008, 181, 8-15.
88. Thai, T. H.; Calado, D. P.; Casola, S.; Ansel, K. M.; Xiao, C.; Xue, Y.; Murphy, A.; Frendewey, D.; Valenzuela, D.; Kutok, J. L.; Schmidt-Supprian, M.; Rajewsky, N.; Yancopoulos, G.; Rao, A.; Rajewsky, K. Regulation of the germinal center response by microRNA- 155. Science, 2007, 316, 604-8.
89. Iorio, M. V.; Ferracin, M.; Liu, C. G.; Veronese, A.; Spizzo, R.; Sabbioni, S.; Magri, E.; Pedriali, M.; Fabbri, M.; Campiglio, M.; Menard, S.; Palazzo, J. P.; Rosenberg, A.; Musiani, P.; Volinia, S.; Nenci, I.; Calin, G. A.; Querzoli, P.; Negrini, M.; Croce, C. M. MicroRNA gene expression deregulation in human breast cancer. Cancer Res., 2005, 65, 7065-70.
90. Gironella, M.; Seux, M.; Xie, M. J.; Cano, C.; Tomasini, R.; Gommeaux, J.; Garcia, S.; Nowak, J.; Yeung, M. L.; Jeang, K. T.; Chaix, A.; Fazli, L.; Motoo, Y.; Wang, Q.; Rocchi, P.; Russo, A.; Gleave, M.; Dagorn, J. C.; Iovanna, J. L.; Carrier, A.; Pebusque, M. J.; Dusetti, N. J. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc. Natl. Acad. Sci. USA, 2007, 104, 16170-5.
91. Nikiforova, M. N.; Tseng, G. C.; Steward, D.; Diorio, D.; Nikiforov, Y. E. MicroRNA expression profiling of thyroid tumors: Biological significance and diagnostic utility. J. Clin. Endocrinol. Metab., 2008.
92. O'Connell, R. M.; Taganov, K. D.; Boldin, M. P.; Cheng, G.; Baltimore, D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl. Acad. Sci. USA, 2007, 104, 1604-9.
93. Tili, E.; Michaille, J. J.; Cimino, A.; Costinean, S.; Dumitru, C. D.; Adair, B.; Fabbri, M.; Alder, H.; Liu, C. G.; Calin, G. A.; Croce, C. M. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/ TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J. Immunol., 2007, 179, 5082-9.
94. Martin, M. M.; Lee, E. J.; Buckenberger, J. A.; Schmittgen, T. D.; Elton, T. S. MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. J. Biol. Chem., 2006, 281, 18277-84.
95. Stanczyk, J.; Pedrioli, D. M.; Brentano, F.; Sanchez-Pernaute, O.; Kolling, C.; Gay, R. E.; Detmar, M.; Gay, S.; Kyburz, D. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum., 2008, 58, 1001-1009.
96. Haasch, D.; Chen, Y. W.; Reilly, R. M.; Chiou, X. G.; Koterski, S.; Smith, M. L.; Kroeger, P.; McWeeny, K.; Halbert, D. N.; Mollison, K. W.; Djuric, S. W.; Trevillyan, J. M. T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC. Cell Immunol., 2002, 217, 78-86.
97. Chan, J. A.; Krichevsky, A. M.; Kosik, K. S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res., 2005, 65, 6029-33.
98. Roldo, C.; Missiaglia, E.; Hagan, J. P.; Falconi, M.; Capelli, P.; Bersani, S.; Calin, G. A.; Volinia, S.; Liu, C. G.; Scarpa, A.; Croce, C. M. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J. Clin. Oncol., 2006, 24, 4677-84.
99. Feber, A.; Xi, L.; Luketich, J. D.; Pennathur, A.; Landreneau, R. J.; Wu, M.; Swanson, S. J.; Godfrey, T. E.; Litle, V. R. MicroRNA expression profiles of esophageal cancer. J. Thorac. Cardiovasc. Surg., 2008, 135, 255-60.
100. Schetter, A. J.; Leung, S. Y.; Sohn, J. J.; Zanetti, K. A.; Bowman, E. D.; Yanaihara, N.; Yuen, S. T.; Chan, T. L.; Kwong, D. L.; Au, G. K.; Liu, C. G.; Calin, G. A.; Croce, C. M.; Harris, C. C. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA, 2008, 299, 425-36.
101. Slaby, O.; Svoboda, M.; Fabian, P.; Smerdova, T.; Knoflickova, D.; Bednarikova, M.; Nenutil, R.; Vyzula, R. Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology, 2007, 72, 397-402
102. Tran, N.; McLean, T.; Zhang, X.; Zhao, C. J.; Thomson, J. M.; O'Brien, C.; Rose, B. MicroRNA expression profiles in head and neck cancer cell lines. Biochem. Biophys. Res. Commun., 2007, 358, 12-7.
103. Jiang, J.; Gusev, Y.; Aderca, I.; Mettler, T. A.; Nagorney, D. M.; Brackett, D. J.; Roberts, L. R.; Schmittgen, T. D. Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin. Cancer Res., 2008, 14, 419-27.
104. Si, M. L.; Zhu, S.; Wu, H.; Lu, Z.; Wu, F.; Mo, Y. Y. miR-21-mediated tumor growth. Oncogene, 2007, 26, 2799-803.
105. Zhu, S.; Si, M. L.; Wu, H.; Mo, Y. Y. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J. Biol. Chem., 2007, 282, 14328-36.
106. Meng, F.; Henson, R.; Wehbe-Janek, H.; Ghoshal, K.; Jacob, S. T.; Patel, T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology, 2007, 133, 647-58.
107. Asangani, I. A.; Rasheed, S. A.; Nikolova, D. A.; Leupold, J. H.; Colburn, N. H.; Post, S.; Allgayer, H. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene, 2008, 27, 2128-36.
108. Frankel, L. B.; Christoffersen, N. R.; Jacobsen, A.; Lindow, M.; Krogh, A.; Lund, A. H. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem., 2008, 283, 1026-33.
109. Lu, Z.; Liu, M.; Stribinskis, V.; Klinge, C. M.; Ramos, K. S.; Colburn, N. H.; Li, Y. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene, 2008.
110. Zhu, S.; Wu, H.; Wu, F.; Nie, D.; Sheng, S.; Mo, Y. Y. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res., 2008, 18, 350-9.
111. Fabbri, M.; Garzon, R.; Cimmino, A.; Liu, Z.; Zanesi, N.; Callegari, E.; Liu, S.; Alder, H.; Costinean, S.; Fernandez-Cymering, C.; Volinia, S.; Guler, G.; Morrison, C. D.; Chan, K. K.; Marcucci, G.; Calin, G. A.; Huebner, K.; Croce, C. M. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl. Acad. Sci. USA, 2007, 104, 15805-10.
112. Lee, Y. S.; Kim, H. K.; Chung, S.; Kim, K. S.; Dutta, A. Depletion of human microRNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the down-regulation of putative targets during differentiation. J. Biol. Chem., 2005, 18, 18.
113. Harris, T. A.; Yamakuchi, M.; Ferlito, M.; Mendell, J. T.; Lowenstein, C. J. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc. Natl. Acad. Sci. USA, 2008, 105, 1516-21.
114. Tavazoie, S. F.; Alarcon, C.; Oskarsson, T.; Padua, D.; Wang, Q.; Bos, P. D.; Gerald, W. L.; Massague, J. Endogenous human microRNAs that suppress breast cancer metastasis. Nature, 2008, 451, 147-52.
115. Crawford, M.; Brawner, E.; Batte, K.; Yu, L.; Hunter, M. G.; Otterson, G. A.; Nuovo, G.; Marsh, C. B.; Nana-Sinkam, S. P. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem. Biophys. Res. Commun., 2008, 373, 607-12.
116. Garofalo, M.; Quintavalle, C.; Di Leva, G.; Zanca, C.; Romano, G.; Taccioli, C.; Liu, C. G.; Croce, C. M.; Condorelli, G. MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. Oncogene, 2008.
117. Visone, R.; Russo, L.; Pallante, P.; De Martino, I.; Ferraro, A.; Leone, V.; Borbone, E.; Petrocca, F.; Alder, H.; Croce, C. M.; Fusco, A. MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocr. Relat. Cancer, 2007, 14, 791-8.
118. Galardi, S.; Mercatelli, N.; Giorda, E.; Massalini, S.; Frajese, G. V.; Ciafre, S. A.; Farace, M. G. miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J. Biol. Chem., 2007, 282, 23716-24.
119. le Sage, C.; Nagel, R.; Egan, D. A.; Schrier, M.; Mesman, E.; Mangiola, A.; Anile, C.; Maira, G.; Mercatelli, N.; Ciafre, S. A.; Farace, M. G.; Agami, R. Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J, 2007, 26, 3699-708.
120. He, X.; He, L.; Hannon, G. J. The guardian's little helper: MicroRNAs in the p53 tumor suppressor network. Cancer Res., 2007, 67, 11099-101.
121. Hermeking, H. p53 enters the microRNA world. Cancer Cell, 2007, 12, 414-8.
122. Bommer, G. T.; Gerin, I.; Feng, Y.; Kaczorowski, A. J.; Kuick, R.; Love, R. E.; Zhai, Y.; Giordano, T. J.; Qin, Z. S.; Moore, B. B.; MacDougald, O. A.; Cho, K. R.; Fearon, E. R. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol., 2007, 17, 1298-307.
123. Chang, T. C.; Wentzel, E. A.; Kent, O. A.; Ramachandran, K.; Mullendore, M.; Lee, K. H.; Feldmann, G.; Yamakuchi, M.; Ferlito, M.; Lowenstein, C. J.; Arking, D. E.; Beer, M. A.; Maitra, A.; Mendell, J. T. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell, 2007, 26, 745-52
124. Corney, D. C.; Flesken-Nikitin, A.; Godwin, A. K.; Wang, W.; Nikitin, A. Y. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res., 2007, 67, 8433-8.
125. He, L.; He, X.; Lim, L. P.; de Stanchina, E.; Xuan, Z.; Liang, Y.; Xue, W.; Zender, L.; Magnus, J.; Ridzon, D.; Jackson, A. L.; Linsley, P. S.; Chen, C.; Lowe, S. W.; Cleary, M. A.; Hannon, G. J. A microRNA component of the p53 tumour suppressor network. Nature, 2007, 447, 1130-4.
126. Raver-Shapira, N.; Marciano, E.; Meiri, E.; Spector, Y.; Rosenfeld, N.; Moskovits, N.; Bentwich, Z.; Oren, M. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol. Cell, 2007, 26, 731-43.
127. Tarasov, V.; Jung, P.; Verdoodt, B.; Lodygin, D.; Epanchintsev, A.; Menssen, A.; Meister, G.; Hermeking, H. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: MiR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle, 2007, 6, 1586-93.
128. Tazawa, H.; Tsuchiya, N.; Izumiya, M.; Nakagama, H. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc. Natl. Acad. Sci. USA, 2007, 104, 15472-7.
129. Lal, A.; Kim, H. H.; Abdelmohsen, K.; Kuwano, Y.; Pullmann, R., Jr.; Srikantan, S.; Subrahmanyam, R.; Martindale, J. L.; Yang, X.; Ahmed, F.; Navarro, F.; Dykxhoorn, D.; Lieberman, J.; Gorospe, M. p16(INK4a) translation suppressed by miR-24. PLoS ONE, 2008, 3, e1864.
130. Calin, G. A.; Sevignani, C.; Dumitru, C. D.; Hyslop, T.; Noch, E.; Yendamuri, S.; Shimizu, M.; Rattan, S.; Bullrich, F.; Negrini, M.; Croce, C. M. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA, 2004, 101, 2999-3004.
131. Nagayama, K.; Kohno, T.; Sato, M.; Arai, Y.; Minna, J. D.; Yokota, J. Homozygous deletion scanning of the lung cancer genome at a 100-kb resolution. Genes Chromosomes Cancer, 2007, 46, 1000-10.
132. Weiss, G. J.; Bemis, L. T.; Nakajima, E.; Sugita, M.; Birks, D. K.; Robinson, W. A.; Varella-Garcia, M.; Bunn, P. A., Jr.; Haney, J.; Helfrich, B. A.; Kato, H.; Hirsch, F. R.; Franklin, W. A. EGFR regulation by microRNA in lung cancer: Correlation with clinical response and survival to gefitinib and EGFR expression in cell lines. Ann. Oncol., 2008, 19, 1053-9.
133. Lee, Y. S.; Dutta, A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev., 2007, 21, 1025-30.
134. Diederichs, S.; Haber, D. A. Sequence variations of microRNAs in human cancer: Alterations in predicted secondary structure do not affect processing. Cancer Res., 2006, 66, 6097-104.
135. Hu, Z.; Chen, J.; Tian, T.; Zhou, X.; Gu, H.; Xu, L.; Zeng, Y.; Miao, R.; Jin, G.; Ma, H.; Chen, Y.; Shen, H. Genetic variants of miRNA sequences and non-small cell lung cancer survival. J. Clin. Invest., 2008, 118, 2600-8.
136. Sandberg, R.; Neilson, J. R.; Sarma, A.; Sharp, P. A.; Burge, C. B. Proliferating cells express mRNAs with shortened 3′ untranslated regions and fewer microRNA target sites. Science, 2008, 320, 1643-7.
137. Lujambio, A.; Ropero, S.; Ballestar, E.; Fraga, M. F.; Cerrato, C.; Setien, F.; Casado, S.; Suarez-Gauthier, A.; Sanchez-Cespedes, M.; Git, A.; Spiteri, I.; Das, P. P.; Caldas, C.; Miska, E.; Esteller, M. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res., 2007, 67, 1424-9.
138. Brueckner, B.; Stresemann, C.; Kuner, R.; Mund, C.; Musch, T.; Meister, M.; Sultmann, H.; Lyko, F. The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. Cancer Res., 2007, 67, 1419-23.
139. Thomson, J. M.; Newman, M.; Parker, J. S.; Morin-Kensicki, E. M.; Wright, T.; Hammond, S. M. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev., 2006, 20, 2202-7.
140. Kluiver, J.; van den Berg, A.; de Jong, D.; Blokzijl, T.; Harms, G.; Bouwman, E.; Jacobs, S.; Poppema, S.; Kroesen, B. J. Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma. Oncogene, 2007, 26, 3769-76.
141. Viswanathan, S. R.; Daley, G. Q.; Gregory, R. I. Selective blockade of microRNA processing by Lin28. Science, 2008, 320, 97-100.
142. Piskounova, E.; Viswanathan, S. R.; Janas, M.; LaPierre, R. J.; Daley, G. Q.; Sliz, P.; Gregory, R. I. Determinants of microRNA processing inhibition by the developmentally regulated RNA-binding protein Lin28. J. Biol. Chem., 2008, 283, 21310-4.
143. Harris, K. S.; Zhang, Z.; McManus, M. T.; Harfe, B. D.; Sun, X. Dicer function is essential for lung epithelium morphogenesis. Proc. Natl. Acad. Sci. USA, 2006, 103, 2208-13.
144. Karube, Y.; Tanaka, H.; Osada, H.; Tomida, S.; Tatematsu, Y.; Yanagisawa, K.; Yatabe, Y.; Takamizawa, J.; Miyoshi, S.; Mitsudomi, T.; Takahashi, T. Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci., 2005, 96, 111-5.
145. Chiosea, S.; Jelezcova, E.; Chandran, U.; Luo, J.; Mantha, G.; Sobol, R. W.; Dacic, S. Overexpression of Dicer in precursor lesions of lung adenocarcinoma. Cancer Res., 2007, 67, 2345-50
146. Nakamura, T.; Canaani, E.; Croce, C. M. Oncogenic All1 fusion proteins target Drosha-mediated microRNA processing. Proc. Natl. Acad. Sci. USA, 2007, 104, 10980-5.
147. Lee, Y.; Kim, M.; Han, J.; Yeom, K. H.; Lee, S.; Baek, S. H.; Kim, V. N. MicroRNA genes are transcribed by RNA polymerase II. EMBO J., 2004, 23, 4051-60.
148. Cai, X.; Hagedorn, C. H.; Cullen, B. R. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA, 2004, 10, 1957-66.
149. Rodriguez, A.; Griffiths-Jones, S.; Ashurst, J. L.; Bradley, A. Identification of mammalian microRNA host genes and transcription units. Genome Res., 2004, 14, 1902-10.
150. Chang, T. C.; Yu, D.; Lee, Y. S.; Wentzel, E. A.; Arking, D. E.; West,
151. Lotterman, C. D.; Kent, O. A.; Mendell, J. T. Functional integration of microRNAs into oncogenic and tumor suppressor pathways. Cell Cycle, 2008, 7, 2493-9.
152. Camps, C.; Buffa, F. M.; Colella, S.; Moore, J.; Sotiriou, C.; Sheldon, H.; Harris, A. L.; Gleadle, J. M.; Ragoussis, J. hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin. Cancer Res., 2008, 14, 1340-8.
153. Giannakakis, A.; Sandaltzopoulos, R.; Greshock, J.; Liang, S.; Huang, J.; Hasegawa, K.; Li, C.; O'Brien-Jenkins, A.; Katsaros, D.; Weber, B. L.; Simon, C.; Coukos, G.; Zhang, L. miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol. Ther., 2007, 7, 255-64.
154. Yu, S. L.; Chen, H. Y.; Chang, G. C.; Chen, C. Y.; Chen, H. W.; Singh, S.; Cheng, C. L.; Yu, C. J.; Lee, Y. C.; Chen, H. S.; Su, T. J.; Chiang, C. C.; Li, H. N.; Hong, Q. S.; Su, H. Y.; Chen, C. C.; Chen, W. J.; Liu, C. C.; Chan, W. K.; Li, K. C.; Chen, J. J.; Yang, P. C. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell, 2008, 13, 48-57.
155. Beer, D. G.; Kardia, S. L.; Huang, C. C.; Giordano, T. J.; Levin, A. M.; Misek, D. E.; Lin, L.; Chen, G.; Gharib, T. G.; Thomas, D. G.; Lizyness, M. L.; Kuick, R.; Hayasaka, S.; Taylor, J. M.; Iannettoni, M. D.; Orringer, M. B.; Hanash, S. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat. Med., 2002, 8, 816-24.
156. Bhattacharjee, A.; Richards, W. G.; Staunton, J.; Li, C.; Monti, S.; Vasa, P.; Ladd, C.; Beheshti, J.; Bueno, R.; Gillette, M.; Loda, M.; Weber, G.; Mark, E. J.; Lander, E. S.; Wong, W.; Johnson, B. E.; Golub, T. R.; Sugarbaker, D. J.; Meyerson, M. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. USA, 2001, 98, 13790-5.
157. Chen, H. Y.; Yu, S. L.; Chen, C. H.; Chang, G. C.; Chen, C. Y.; Yuan, A.; Cheng, C. L.; Wang, C. H.; Terng, H. J.; Kao, S. F.; Chan, W. K.; Li, H. N.; Liu, C. C.; Singh, S.; Chen, W. J.; Chen, J. J.; Yang, P. C. A five-gene signature and clinical outcome in non-small-cell lung cancer. N. Engl. J. Med., 2007, 356, 11-20.
158. Garber, M. E.; Troyanskaya, O. G.; Schluens, K.; Petersen, S.; Thaesler, Z.; Pacyna-Gengelbach, M.; van de Rijn, M.; Rosen, G. D.; Perou, C. M.; Whyte, R. I.; Altman, R. B.; Brown, P. O.; Botstein, D.; Petersen, I. Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. USA, 2001, 98, 13784-9.
159. Granville, C. A.; Dennis, P. A. An overview of lung cancer genomics and proteomics. Am. J. Respir. Cell. Mol. Biol., 2005, 32, 169-76.
160. Wigle, D. A.; Jurisica, I.; Radulovich, N.; Pintilie, M.; Rossant, J.; Liu, N.; Lu, C.; Woodgett, J.; Seiden, I.; Johnston, M.; Keshavjee, S.; Darling, G.; Winton, T.; Breitkreutz, B. J.; Jorgenson, P.; Tyers, M.; Shepherd, F. A.; Tsao, M. S. Molecular profiling of non-small cell lung cancer and correlation with disease-free survival. Cancer Res., 2002, 62, 3005-8.
161. Lara, P. N., Jr.; Redman, M. W.; Kelly, K.; Edelman, M. J.; Williamson, S. K.; Crowley, J. J.; Gandara, D. R. Disease control rate at 8 weeks predicts clinical benefit in advanced non-small-cell lung cancer: results from Southwest Oncology Group randomized trials. J. Clin. Oncol., 2008, 26, 463-7.
162. Weidhaas, J. B.; Babar, I.; Nallur, S. M.; Trang, P.; Roush, S.; Boehm, M.; Gillespie, E.; Slack, F. J. MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Res., 2007, 67, 11111-6.
163. Blower, P. E.; Verducci, J. S.; Lin, S.; Zhou, J.; Chung, J. H.; Dai, Z.; Liu, C. G.; Reinhold, W.; Lorenzi, P. L.; Kaldjian, E. P.; Croce, C. M.; Weinstein, J. N.; Sadee, W. MicroRNA expression profiles for the NCI-60 cancer cell panel. Mol. Cancer Ther., 2007, 6, 1483-91.
164. Marquez, R. T.; McCaffrey, A. P. Advances in microRNAs: Implications for gene therapists. Hum. Gene Ther., 2008, 19, 27-38
165. Ebert, M. S.; Neilson, J. R.; Sharp, P. A. MicroRNA sponges: Competitive inhibitors of small RNAs in mammalian cells. Nat. Methods, 2007, 4, 721-6.
166. Meister, G.; Landthaler, M.; Dorsett, Y.; Tuschl, T. Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA, 2004, 10, 544-50.
167. Rudin, C. M.; Salgia, R.; Wang, X.; Hodgson, L. D.; Masters, G. A.; Green, M.; Vokes, E. E. Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103. J. Clin. Oncol., 2008, 26, 870-6.
168. Krutzfeldt, J.; Rajewsky, N.; Braich, R.; Rajeev, K. G.; Tuschl, T.; Manoharan, M.; Stoffel, M. Silencing of microRNAs in vivo with 'antagomirs'. Nature, 2005, 438, 685-9.
169. Esau, C.; Davis, S.; Murray, S. F.; Yu, X. X.; Pandey, S. K.; Pear, M.; Watts, L.; Booten, S. L.; Graham, M.; McKay, R.; Subramaniam, A.; Propp, S.; Lollo, B. A.; Freier, S.; Bennett, C. F.; Bhanot, S.; Monia, B. P. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab., 2006, 3, 87-98
170. Felicetti, F.; Errico, M. C.; Bottero, L.; Segnalini, P.; Stoppacciaro, A.; Biffoni, M.; Felli, N.; Mattia, G.; Petrini, M.; Colombo, M. P.; Peschle, C.; Care, A. The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Res., 2008, 68, 2745-54.
171. Dickins, R. A.; McJunkin, K.; Hernando, E.; Premsrirut, P. K.; Krizhanovsky, V.; Burgess, D. J.; Kim, S. Y.; Cordon-Cardo, C.; Zender, L.; Hannon, G. J.; Lowe, S. W. Tissue-specific and reversible RNA interference in transgenic mice. Nat. Genet., 2007, 39, 914-21.
172. Izquierdo, M. Short interfering RNAs as a tool for cancer gene therapy. Cancer Gene Ther., 2005, 12, 217-27.
173. Bedikian, A. Y.; Millward, M.; Pehamberger, H.; Conry, R.; Gore, M.; Trefzer, U.; Pavlick, A. C.; DeConti, R.; Hersh, E. M.; Hersey, P.; Kirkwood, J. M.; Haluska, F. G. Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: The Oblimersen Melanoma Study Group. J. Clin. Oncol., 2006, 24, 4738-45
174. Kleinman, M. E.; Yamada, K.; Takeda, A.; Chandrasekaran, V.; Nozaki, M.; Baffi, J. Z.; Albuquerque, R. J.; Yamasaki, S.; Itaya, M.; Pan, Y.; Appukuttan, B.; Gibbs, D.; Yang, Z.; Kariko, K.; Ambati, B. K.; Wilgus, T. A.; DiPietro, L. A.; Sakurai, E.; Zhang, K.; Smith, J. R.; Taylor, E. W.; Ambati, J. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature, 2008, 452, 591-7.
175. Robbins, M.; Judge, A.; Liang, L.; McClintock, K.; Yaworski, E.; MacLachlan, I. 2prime-O-methyl-modified RNAs Act as TLR7 Antagonists. Mol. Ther., 2007, 15, 1663-1669.
176. Akinc, A.; Zumbuehl, A.; Goldberg, M.; Leshchiner, E. S.; Busini, V.; Hossain, N.; Bacallado, S. A.; Nguyen, D. N.; Fuller, J.; Alvarez, R.; Borodovsky, A.; Borland, T.; Constien, R.; de Fougerolles, A.; Dorkin, J. R.; Narayanannair Jayaprakash, K.; Jayaraman, M.; John, M.; Koteliansky, V.; Manoharan, M.; Nechev, L.; Qin, J.; Racie, T.; Raitcheva, D.; Rajeev, K. G.; Sah, D. W. Y.; Soutschek, J.; Toudjarska, I.; Vornlocher, H.-P.; Zimmermann, T. S.; Langer, R.; Anderson, D. G. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat. Biotech., 2008, 26, 561-569